DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for ECL RT biochemical assay are 12

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_6510	MK-1439	Antiviral	Acquired immunodeficiency syndrome	Human immunodeficiency virus	Wild type		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6511	Efavirenz	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	Wild type		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6512	Etravirine	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	Wild type		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6513	Rilpivirine	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	Wild type		ECL RT biochemical assay	Decrease (50 %)	Approved	24379202
DrugRepV_6514	MK-1439	Antiviral	Acquired immunodeficiency syndrome	Human immunodeficiency virus	K103N		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6515	Efavirenz	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	K103N		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6516	Etravirine	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	K103N		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6517	Rilpivirine	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	K103N		ECL RT biochemical assay	Decrease (50 %)	Approved	24379202
DrugRepV_6518	MK-1439	Antiviral	Acquired immunodeficiency syndrome	Human immunodeficiency virus	Y181C		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6519	Efavirenz	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	Y181C		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6520	Etravirine	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	Y181C		ECL RT biochemical assay	Decrease (50 %)	NA	24379202
DrugRepV_6521	Rilpivirine	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	Y181C		ECL RT biochemical assay	Decrease (50 %)	Approved	24379202